People · Operator
Named in public records as an officer, director or promoter · active 2017–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SutroVax, Inc. | — | Biotechnology | Series D+ | $205.9M | $4.5B | 2017 |
| Bolt Biotherapeutics, Inc. | — | Biotechnology | Series C | $178.6M | $433.3M | 2019 |
| Fountain Therapeutics, Inc. | — | Biotechnology | Series B | $26.9M | $348.9M | 2020 |
Ashish Khanna at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ashish Khanna on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Heron | 1 | 11 |
| Alex Morgan | 1 | 10 |
| Patrick Enright | 1 | 10 |
| Richard Miller | 1 | 8 |
| James Healy | 1 | 8 |
| Peter Hirth | 1 | 7 |
| Patrick J. Heron | 1 | 7 |
| Kurt Von Emster | 1 | 6 |
| Peter Moldt | 1 | 6 |
| William Greene | 1 | 6 |
| Tracy Saxton | 1 | 5 |
| Mahendra Shah | 1 | 5 |
| Edgar G Engleman | 1 | 5 |
| William J. Newell | 1 | 3 |
| Mahendra G. Shah | 1 | 3 |
| Elaine Sun | 1 | 3 |
| Reiner Laus | 1 | 2 |
| Chih-Ping Liu | 1 | 2 |
| William Newell | 1 | 2 |
| Grant E Pickering | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.